Part B: Supplementary Information Sheet (SIS) |
FR Recognition List Number
|
055
|
Date of Entry 12/21/2020
|
FR Recognition Number
|
10-121
|
Standard | |
ISO 16672 Third edition 2020-06 Ophthalmic implants - Ocular endotamponades |
|
Scope/AbstractThis document applies to ocular endotamponades (OE), a group of non-solid surgically invasive medical devices introduced into the vitreous cavity of the eye to flatten and position a detached retina onto the retinal pigment epithelium (RPE), or to tamponade the retina. With regard to the safety and efficacy of OE, this document specifies requirements for their intended performance, design attributes, pre-clinical and clinical evaluation, sterilization, product packaging, product labelling and the information supplied by the manufacturer. |
|
Extent of Recognition
|
Rationale for Recognition
This standard is relevant to medical devices and is recognized on its scientific and technical merit and/or because it supports existing regulatory policies. |
|
Public Law, CFR Citation(s) and Procode(s)*
Regulation Number |
Device Name |
Device Class |
Product Code |
§886.4270 |
Gases Used Within Eye To Place Pressure On Detached Retina
|
Class 3
|
LPO
|
§886.4275 |
Fluid, Intraocular
|
Class 3
|
LWL
|
|
Relevant FDA Guidance and/or Supportive Publications*
Appropriate Use of Voluntary Consensus Standards in Premarket Submissions for Medical Devices - Guidance for Industry and Food and Drug Administration Staff, issued September 2018. |
|
FDA Technical Contact
|
Standards Development Organization
|
FDA Specialty Task Group (STG)
|
*These are provided as examples and others may be applicable. |